There are 3161 resources available
141P - Circulating immune cells predict immunotherapy benefit in patients with triple negative breast cancer: Preliminary results from the IRIS study
Presenter: Benedetta Conte
Session: Poster session 08
142P - Exploring tumor mutational burden and frameshift mutations as predictors of immune checkpoint inhibitor efficacy
Presenter: Mai Hoshino
Session: Poster session 08
143P - Efficacy of immunotherapy in gastro-intestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype
Presenter: Emily Alouani
Session: Poster session 08
144P - Analysis of a novel predictive marker of immune checkpoint response in head and neck cancer, calculated from histopathological slides through inferred transcriptomics
Presenter: Johnathan Arnon
Session: Poster session 08
145P - Predicting the efficacy of immunotherapy in non-small cell lung cancer using machine learning based on simple clinical characteristics and biochemical indexes
Presenter: Lei Cheng
Session: Poster session 08
146P - Biomarkers and intrinsic/acquired resistance mechanisms for atezolizumab plus chemoradiotherapy in MSS locally advanced rectal cancer: An exploratory analysis of a single center, phase II study
Presenter: Wentao Tang
Session: Poster session 08
147P - Comparison of immune-checkpoint inhibitor therapy predictive marker tests microsatellite instability (MSI) and mismatch-repair deficiency (dMMR)
Presenter: Maja Nádorvári
Session: Poster session 08
148P - Clinical significance of CD4+ T cell subsets in peripheral blood for anti-PD-1/PD-L1 therapy
Presenter: Yoshimichi Haruna
Session: Poster session 08
149P - Evaluation of HLA genotype as predictive biomarker for immunological and clinical responses upon vaccination with PolyPEPI1018 cancer vaccine against colorectal cancer
Presenter: Joleen Hubbard
Session: Poster session 08
150P - Phase I/IIa trial of CD200R1 inhibitor 23ME-00610: Exploratory analyses of tissue-based and genetic biomarkers
Presenter: Albiruni Ryan Abdul Razak
Session: Poster session 08